These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15760095)

  • 1. The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model.
    Nikas SP; Grzybowska J; Papahatjis DP; Charalambous A; Banijamali AR; Chari R; Fan P; Kourouli T; Lin S; Nitowski AJ; Marciniak G; Guo Y; Li X; Wang CL; Makriyannis A
    AAPS J; 2004 Oct; 6(4):e30. PubMed ID: 15760095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
    Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
    J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol.
    Khanolkar AD; Lu D; Fan P; Tian X; Makriyannis A
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2119-24. PubMed ID: 10465529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency.
    Keimowitz AR; Martin BR; Razdan RK; Crocker PJ; Mascarella SW; Thomas BF
    J Med Chem; 2000 Jan; 43(1):59-70. PubMed ID: 10633038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
    Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
    J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adamantyl cannabinoids: a novel class of cannabinergic ligands.
    Lu D; Meng Z; Thakur GA; Fan P; Steed J; Tartal CL; Hurst DP; Reggio PH; Deschamps JR; Parrish DA; George C; Järbe TU; Lamb RJ; Makriyannis A
    J Med Chem; 2005 Jul; 48(14):4576-85. PubMed ID: 15999995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
    Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
    Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
    Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
    J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
    Krishnamurthy M; Gurley S; Moore BM
    Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
    Lu D; Guo J; Duclos RI; Bowman AL; Makriyannis A
    J Med Chem; 2008 Oct; 51(20):6393-9. PubMed ID: 18826296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
    Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
    J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.
    Shim JY; Bertalovitz AC; Kendall DA
    J Biol Chem; 2011 Sep; 286(38):33422-35. PubMed ID: 21795705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
    Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
    J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.
    Huffman JW; Hepburn SA; Lyutenko N; Thompson AL; Wiley JL; Selley DE; Martin BR
    Bioorg Med Chem; 2010 Nov; 18(22):7809-15. PubMed ID: 20943404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.
    Picone RP; Khanolkar AD; Xu W; Ayotte LA; Thakur GA; Hurst DP; Abood ME; Reggio PH; Fournier DJ; Makriyannis A
    Mol Pharmacol; 2005 Dec; 68(6):1623-35. PubMed ID: 16157695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
    Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
    Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-functionalized adamantyl cannabinoid receptor probes.
    Ogawa G; Tius MA; Zhou H; Nikas SP; Halikhedkar A; Mallipeddi S; Makriyannis A
    J Med Chem; 2015 Apr; 58(7):3104-16. PubMed ID: 25760146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.
    Nikas SP; Alapafuja SO; Papanastasiou I; Paronis CA; Shukla VG; Papahatjis DP; Bowman AL; Halikhedkar A; Han X; Makriyannis A
    J Med Chem; 2010 Oct; 53(19):6996-7010. PubMed ID: 20925434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.